Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients
Post-hoc analysis demonstrated that a single intramyocardial CSCC_ASC injection in patients with chronic ischemic no-option HF did not improve cardiac function.
Authors
- Abbas Ali Qayyum (ORCID: https://orcid.org/0000-0002-1620-0002)
- Jens Kastrup (ORCID: https://orcid.org/0000-0002-3668-5393)
- Nadia Chaaban
Institutions
- University of Copenhagen (DK)
- Hvidovre Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Regenerative Medicine
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1080/17460751.2025.2574194
- Citations
- 2
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Horizon 2020 Framework Programme